Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells

Cancer Science

Volumn 103, Issue 5, 2012, Pages 860-867

  Ogawa, Kumiko ^a,b   Pitchakarn, Pornsiri ^a,c   Suzuki, Shugo ^a   Chewonarin, Teera ^a,c   Tang, Mingxi ^a,d   Takahashi, Seishiro ^a   Naiki Ito, Aya ^a   Sato, Shinya ^a   Takahashi, Satoru ^a   Asamoto, Makoto ^a   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c Faculty of Medicine Chiang Mai University   (Thailand)

^d SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER MORTALITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CONNEXIN 43; GENE SILENCING; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RATS;

EID: 84860250064     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02228.x     Document Type: Article

References (40)

1. Ogawa K, Nakanishi H, Takeshita F et al. Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice. Int J Cancer 2001; 91: 797-802.
2. Masui T, Nakanishi H, Inada K-I et al. Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes. Cancer Lett 1997; 112: 33-45.
3. Futakuchi M, Hirose M, Ogiso T et al. Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model. Jpn J Cancer Res 1999; 90: 1196-202.
4. Yoshino H, Futakuchi M, Cho YM et al. Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine. Clin Exp Metastasis 2005; 22: 441-7.
5. Sato K, Kitahara A, Satoh K, Ishikawa T, Tatematsu M, Ito N. The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Gann 1984; 75: 199-202.
6. Ito N, Tsuda H, Tatematsu M et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 1988; 9: 387-94.
7. Ogiso T, Tatematsu M, Tamano S, Hasegawa R, Ito N. Correlation between medium-term liver bioassay system data and results of long-term testing in rats. Carcinogenesis 1990; 11: 561-6.
8. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
9. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999; 91: 1113-24.
10. Waguri N, Suda T, Nomoto M et al. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin Cancer Res 2003; 9: 3004-11.
11. Riethdorf S, Wikman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008; 123: 1991-2006.
12. Kobayashi K, Nakanishi H, Masuda A, Tezuka N, Mutai M, Tatematsu M. Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cells. Cancer Lett 1997; 112: 191-8.
13. Watanabe T, Katsura Y, Yoshitake A, Masataki H, Mori T. IPAP: image processor for analytical pathology. J Toxicol Pathol 1994; 7: 353-61.
14. Tsuda H, Asamoto M, Baba H et al. Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin 32 expression. Carcinogenesis 1995; 16: 101-5.
15. Asamoto M, Hokaiwado N, Murasaki T, Shirai T. Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. Hepatology 2004; 40: 205-10.
16. Hokaiwado N, Asamoto M, Futakuchi M, Ogawa K, Takahashi S, Shirai T. Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication. J Membr Biol 2007; 218: 101-6.
17. Naiki-Ito A, Asamoto M, Naiki T et al. Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol 2010; 38: 280-6.
18. Villares GJ, Dobroff AS, Wang H et al. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res 2009; 69: 6730-7.
19. El-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol 1991; 115: 1375-82.
20. Elzarrad MK, Haroon A, Willecke K, Dobrowolski R, Gillespie MN, Al-Mehdi AB. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 2008; 6: 20.
21. Lin JH, Takano T, Cotrina ML et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 2002; 22: 4302-11.
22. Zhang W, Nwagwu C, Le DM, Yong VW, Song H, Couldwell WT. Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg 2003; 99: 1039-46.
23. Xu HT, Li QC, Zhang YX et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol 2008; 46: 315-21.
24. Li Z, Zhou Z, Donahue HJ. Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis 2008; 25: 265-72.
25. McLachlan E, Shao Q, Wang HL, Langlois S, Laird DW. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 2006; 66: 9886-94.
26. Willecke K, Eiberger J, Degen J et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725-37.
27. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 1997; 7: 713-6.
28. King TJ, Lampe PD. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 2004; 25: 669-80.
29. King TJ, Lampe PD. The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res 2004; 64: 7191-6.
30. Goldberg GS, Lampe PD, Nicholson BJ. Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat Cell Biol 1999; 1: 457-9.
31. Tapiero H, Townsend DM, Tew KD. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 2004; 58: 100-10.
32. Balendiran GK, Dabur R, Fraser D. The role of glutathione in cancer. Cell Biochem Funct 2004; 22: 343-52.
33. Kim J, Hong SJ, Park JY et al. Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Sci 2010; 101: 1521-8.
34. Li J, Lau GK-K, Chen L et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS ONE 2011; 6: e21816.
35. Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ. Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res 1998; 83: 1248-63.
36. Donahue HJ, McLeod KJ, Rubin CT et al. Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J Bone Miner Res 1995; 10: 881-9.
37. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 2001; 51: 217-29.
38. Swenson KI, Jordan JR, Beyer EC, Paul DL. Formation of gap junctions by expression of connexins in Xenopus oocyte pairs. Cell 1989; 57: 145-55.
39. White TW, Paul DL, Goodenough DA, Bruzzone R. Functional analysis of selective interactions among rodent connexins. Mol Biol Cell 1995; 6: 459-70.
40. Gemel J, Valiunas V, Brink PR, Beyer EC. Connexin43 and connexin26 form gap junctions, but not heteromeric channels in co-expressing cells. J Cell Sci 2004; 117: 2469-80.